Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1970 1
1971 2
1972 2
1973 1
1974 3
1975 7
1976 7
1977 4
1978 6
1979 9
1980 14
1981 26
1982 32
1983 34
1984 50
1985 58
1986 62
1987 70
1988 73
1989 100
1990 141
1991 120
1992 114
1993 138
1994 166
1995 179
1996 201
1997 194
1998 225
1999 195
2000 255
2001 300
2002 323
2003 366
2004 339
2005 386
2006 358
2007 374
2008 394
2009 399
2010 407
2011 507
2012 456
2013 492
2014 523
2015 567
2016 560
2017 594
2018 588
2019 636
2020 662
2021 748
2022 723
2023 706
2024 667
2025 787
2026 204

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,822 results

Results by year

Filters applied: . Clear all
Page 1
Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations.
Baumrin E, Loren AW, Falk SJ, Mays JW, Cowen EW. Baumrin E, et al. J Am Acad Dermatol. 2024 Jan;90(1):1-16. doi: 10.1016/j.jaad.2022.12.024. Epub 2022 Dec 23. J Am Acad Dermatol. 2024. PMID: 36572065 Free PMC article. Review.
Chronic graft-versus-host disease is a major complication of allogeneic hematopoietic cell transplantation and a leading cause of long-term morbidity, nonrelapse mortality, and impaired health-related quality of life. ...Food and Drug Administra …
Chronic graft-versus-host disease is a major complication of allogeneic hematopoietic cell transplantatio …
Updates in chronic graft-versus-host disease management.
Malard F, Mohty M. Malard F, et al. Am J Hematol. 2023 Oct;98(10):1637-1644. doi: 10.1002/ajh.27040. Epub 2023 Jul 22. Am J Hematol. 2023. PMID: 37483142 Free article. Review.
Chronic graft-versus-host disease (cGvHD) remains the most important long-term complication of allogeneic hematopoietic cell transplantation (allo-HCT), but the field has seen significant changes in the last decade. ...
Chronic graft-versus-host disease (cGvHD) remains the most important long-term complication of allogeneic …
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
Bolaños-Meade J, Hamadani M, Wu J, Al Malki MM, Martens MJ, Runaas L, Elmariah H, Rezvani AR, Gooptu M, Larkin KT, Shaffer BC, El Jurdi N, Loren AW, Solh M, Hall AC, Alousi AM, Jamy OH, Perales MA, Yao JM, Applegate K, Bhatt AS, Kean LS, Efebera YA, Reshef R, Clark W, DiFronzo NL, Leifer E, Horowitz MM, Jones RJ, Holtan SG; BMT CTN 1703 Investigators. Bolaños-Meade J, et al. N Engl J Med. 2023 Jun 22;388(25):2338-2348. doi: 10.1056/NEJMoa2215943. N Engl J Med. 2023. PMID: 37342922 Free PMC article. Clinical Trial.
BACKGROUND: In patients undergoing allogeneic hematopoietic stem-cell transplantation (HSCT), a calcineurin inhibitor plus methotrexate has been a standard prophylaxis against graft-versus-host disease (GVHD). A phase 2 study indicated the potential su …
BACKGROUND: In patients undergoing allogeneic hematopoietic stem-cell transplantation (HSCT), a calcineurin inhibitor plus methotrexate has …
ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults.
Bos S, Murray J, Marchetti M, Cheng GS, Bergeron A, Wolff D, Sander C, Sharma A, Badawy SM, Peric Z, Piekarska A, Pidala J, Raj K, Penack O, Kulkarni S, Beestrum M, Linke A, Rutter M, Coleman C, Tonia T, Schoemans H, Stolz D, Vos R. Bos S, et al. Eur Respir J. 2024 Mar 28;63(3):2301727. doi: 10.1183/13993003.01727-2023. Print 2024 Mar. Eur Respir J. 2024. PMID: 38485149 Free article.
Chronic graft-versus-host disease (cGvHD) is a common complication after allogeneic haematopoietic stem cell transplantation, characterised by a broad disease spectrum that can affect virtually any organ. ...The purpose of this joint Euro …
Chronic graft-versus-host disease (cGvHD) is a common complication after allogeneic haematopoietic stem c …
Chronic graft-versus-host disease. Part II: Disease activity grading and therapeutic management.
Baumrin E, Loren AW, Falk SJ, Mays JW, Cowen EW. Baumrin E, et al. J Am Acad Dermatol. 2024 Jan;90(1):19-36. doi: 10.1016/j.jaad.2022.12.023. Epub 2022 Dec 23. J Am Acad Dermatol. 2024. PMID: 36572064 Free PMC article. Review.
Chronic graft-versus-host disease (cGVHD) is a major complication of allogeneic hematopoietic cell transplantation and a leading cause of long-term morbidity, nonrelapse mortality, and impaired health-related quality of life. ...Part II discusse …
Chronic graft-versus-host disease (cGVHD) is a major complication of allogeneic hematopoietic cell transp …
Ocular graft-versus-host disease (oGVHD): From A to Z.
Soleimani M, Mahdavi Sharif P, Cheraqpour K, Koganti R, Masoumi A, Baharnoori SM, Salabati M, Djalilian AR. Soleimani M, et al. Surv Ophthalmol. 2023 Jul-Aug;68(4):697-712. doi: 10.1016/j.survophthal.2023.02.006. Epub 2023 Mar 2. Surv Ophthalmol. 2023. PMID: 36870423 Free PMC article. Review.
Allogeneic hematopoietic stem cell transplantation is a definitive therapy for a variety of disorders. One of the complications is acute graft-versus-host disease (aGVHD), which has a high mortality rate. Patients can also develop chronic gra …
Allogeneic hematopoietic stem cell transplantation is a definitive therapy for a variety of disorders. One of the complications is acute …
Novel Approaches to the Treatment of Chronic Graft-Versus-Host Disease.
Zeiser R. Zeiser R. J Clin Oncol. 2023 Apr 1;41(10):1820-1824. doi: 10.1200/JCO.22.02256. Epub 2023 Feb 17. J Clin Oncol. 2023. PMID: 36800551 Review.
The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.Chronic graft-versus-host disease (c …
The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal o …
Chronic graft-versus-host disease in pediatric patients: Differences and challenges.
Haroun E, Agrawal K, Leibovitch J, Kassab J, Zoghbi M, Dutta D, Lim SH. Haroun E, et al. Blood Rev. 2023 Jul;60:101054. doi: 10.1016/j.blre.2023.101054. Epub 2023 Feb 8. Blood Rev. 2023. PMID: 36805299 Review.
Despite the use of high-resolution molecular techniques for tissue typing, chronic graft-versus-host disease (cGVHD) remains a major complication following allogeneic hematopoietic stem cell transplant. cGVHD adversely affects the life-expectanc …
Despite the use of high-resolution molecular techniques for tissue typing, chronic graft-versus-host disease …
[Chronic graft-versus-host disease].
Rørvik SD, Abrahamsen IW, Myhre AE, Vo CD, Ødegaard EM, Bruserud Ø, Gedde-Dahl T, Tvedt THA. Rørvik SD, et al. Tidsskr Nor Laegeforen. 2023 Mar 13;143(4). doi: 10.4045/tidsskr.22.0525. Print 2023 Mar 14. Tidsskr Nor Laegeforen. 2023. PMID: 36919292 Free article. Norwegian.
Chronic graft-versus-host disease is a late complication of allogeneic stem cell transplantation and leads to chronic inflammation and fibrosis in various organs due to dysregulation of donor immune cells. ...This article provides a clini …
Chronic graft-versus-host disease is a late complication of allogeneic stem cell transplantation and lead …
Ruxolitinib for the treatment of acute and chronic graft-versus-host disease in children: a systematic review and individual patient data meta-analysis.
Baccelli F, Gottardi F, Muratore E, Leardini D, Grasso AG, Gori D, Belotti T, Prete A, Masetti R. Baccelli F, et al. Bone Marrow Transplant. 2024 Jun;59(6):765-776. doi: 10.1038/s41409-024-02252-z. Epub 2024 Feb 24. Bone Marrow Transplant. 2024. PMID: 38402346 Free PMC article.
Steroid-refractory graft-versus-host disease (SR-GvHD) represents a major complication of pediatric allogenic hematopoietic stem cell transplantation. ...Overall response rate (ORR) ranged from 45% to 100% in both acute and chronic GvHD. Complet …
Steroid-refractory graft-versus-host disease (SR-GvHD) represents a major complication of pediatric allogenic he …
13,822 results
You have reached the last available page of results. Please see the User Guide for more information.